Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
Hepatology International|August 13, 2021
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patientsJee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, et al.Journal of Gastroenterology and Hepatology|July 24, 2025
Steatotic Liver Disease-Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog-Treated Chronic Hepatitis BTyng-Yuan Jang, Chih-Wen Wang, Po-Cheng Liang, et al.Journal of Gastroenterology and Hepatology|November 22, 2025
FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLDYa-Chin Huang, Chih-Wen Wang, Jiun-Chi Huang, et al.Alimentary Pharmacology & Therapeutics|February 19, 2025
Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside AnaloguesTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.Oncotarget|August 20, 2016
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapyMing-Ying Lu, Ching-I Huang, Ming-Yen Hsieh, et al.Medicine|June 1, 2017
Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and databasePei-Chien Tsai, Ta-Wei Liu, Yi-Shan Tsai, et al.World Journal of Gastroenterology|March 17, 2025
Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetesMing-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, et al.The Kaohsiung Journal of Medical Sciences|November 10, 2023
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver diseaseTyng-Yuan Jang, Chi-Chang Ho, Po-Cheng Liang, et al.Journal of the Chinese Medical Association : JCMA|February 13, 2025
Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis BTyng-Yuan Jang, Yu-Ting Zeng, Po-Cheng Liang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 9, 2017
Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohortTa-Wei Liu, Pei-Chien Tsai, Ching-I Huang, et al.Pageof 10